reference/22774087

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22774087

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	344
issn	1474-4422
issueIdentifier	4
pageRange	334-344
publicationName	The Lancet. Neurology
startingPage	334
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_27c8a446e1d8aec258dc36f4b9030355
bibliographicCitation	Collinge J, Gorham M, Hudson F, Kennedy A, Keogh G, Pal S, Rossor M, Rudge P, Siddique D, Spyer M, Thomas D, Walker S, Webb T, Wroe S, Darbyshire J. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. The Lancet Neurology. 2009 Apr;8(4):334–44. doi: 10.1016/s1474-4422(09)70049-3.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f48e80e54786891ecf2e5b9662ae1f47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb6d7d1e755d174ca16e3f68562f6dc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46a80719f46e0bb4cc4ea2a370456c90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e6ea31d63b7d0eb7faba736bd882a73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4625-4052 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_649141da7674043b175753b3191e8df0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18d1cab77cdcd265f7911d47d01efe6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c60e073523415d29bd419059355f4c9c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_826f093102a19c7dc9b662c816a7d0f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2b6386729280d794c2ed6adcabfb90b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10f76e34ae21635f405401b518bcbca8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_840dd9ada82bcaf0ad66ff2c1021651b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8fdceaaadc7a0980b9d588a795b1a74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_277fe3701fed5786cf0e8a4a34bdaa29 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc9a67f8847845df01cd7f693acfe931 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c537933c296e37d9352acdb410d2ea4d
date	200904
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2660392 https://pubmed.ncbi.nlm.nih.gov/19278902 https://doi.org/10.1016/s1474-4422%2809%2970049-3
isPartOf	https://portal.issn.org/resource/ISSN/1474-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30413
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
discusses	http://id.nlm.nih.gov/mesh/M0018330
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011796Q000627 http://id.nlm.nih.gov/mesh/D017096Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000367 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D009483 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D017096Q000401 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D011796Q000008 http://id.nlm.nih.gov/mesh/D012737 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D053208
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8200 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9977 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d99252e0d935cfe5f677c5e5a60da6d4 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID237

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128093762 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128330548 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814614 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127987170 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129589511

Total number of triples: 68.